Eagle LogoPEPTIDE INITIATIVE

Peptide Database

Total Peptides: 32
Back to Home

Thymosin Alpha-1

Tα1, N-Acetyl-Ser-Asp-Ala-Ala-Val-Asp-Thr-Ser-Ser-Glu-Ile-Thr-Thr-Lys-Asp-Leu-Lys-Glu-Lys-Lys-Glu-Val-Val-Glu-Glu-Ala-Glu-Asn

Thymosin Alpha-1 is a potent immunomodulatory peptide that enhances T-lymphocyte function, activates natural killer cells, and strengthens both innate and adaptive immune responses. Originally derived from the thymus gland, it plays a crucial role in immune system maturation and has been extensively studied for treating viral infections, cancer, and immunodeficiency disorders.

Complete Dosing Guide

Quick Reference

1.6mg
Typical Dose
Variable
Frequency
2-4
Half-Life
SubQ
Route

Administration Method

Subcutaneous injection with site rotation between thighs, abdomen, and upper arms

Step-by-Step Dosing Protocol

Initial
1.6mg subcutaneous injection twice weekly
Getting started
Follow gradual escalation approach
Maintenance
Optimized dose
Sustained benefits
Continue at effective dose
Cycling
Break period
Recovery
Take breaks to maintain effectiveness

Dosage Calculator

Dose Calculator

Peptide amount must be greater than 0

Medical Disclaimer

Thymosin Alpha-1 is an investigational peptide not approved by the FDA for medical treatment in the United States. This information is for educational purposes only and should not replace professional medical advice. Consult healthcare providers before use, especially for immune-related conditions or during medical treatments.